Abstract | OBJECTIVE:
Endometriosis is a chronic oestrogen-dependent gynaecological disorder, the most common symptom of which is pain. Inflammation can be considered one of the major causes of pain in endometriosis. In particular, degranulating mast cells have been found in significantly greater quantities in endometriotic lesions than in unaffected tissues. The increase in activated and degranulating mast cells is closely associated with nerve structures in painful endometriotic lesions. These observations indicate that inflammation due to mast cells may contribute to the development of pain and hyperalgesia in endometriosis. Controlling mast-cell activation may therefore relieve the pain associated with endometriotic lesions. STUDY DESIGN: RESULTS: The preliminary results indicate that all patients enrolled experienced pain relief as early as 1 month after starting treatment. Furthermore, a reduction in the analgesic drugs usually employed for pain control was observed in all subjects treated. Additionally, some improvements in endometriotic lesions seemed to be demonstrated by imaging. CONCLUSIONS:
|
Authors | Ugo Indraccolo, Fabrizio Barbieri |
Journal | European journal of obstetrics, gynecology, and reproductive biology
(Eur J Obstet Gynecol Reprod Biol)
Vol. 150
Issue 1
Pg. 76-9
(May 2010)
ISSN: 1872-7654 [Electronic] Ireland |
PMID | 20176435
(Publication Type: Journal Article)
|
Copyright | Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Amides
- Drug Combinations
- Endocannabinoids
- Ethanolamines
- Glucosides
- Palmitic Acids
- Stilbenes
- pelvilen
- palmidrol
- polydatin
|
Topics |
- Adult
- Amides
- Drug Combinations
- Dyspareunia
(drug therapy)
- Endocannabinoids
- Endometriosis
(complications, pathology)
- Ethanolamines
- Female
- Glucosides
(administration & dosage)
- Humans
- Mast Cells
(pathology)
- Middle Aged
- Palmitic Acids
(administration & dosage)
- Pelvic Pain
(drug therapy, etiology)
- Stilbenes
(administration & dosage)
|